{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:44:29Z","timestamp":1789897469320,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1124\/dmd.112.046177","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T05:26:26Z","timestamp":1339737986000},"page":"1817-1824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Altered Arsenic Disposition in Experimental Nonalcoholic Fatty Liver Disease"],"prefix":"10.1016","volume":"40","author":[{"given":"Mark J.","family":"Canet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiannon N.","family":"Hardwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April D.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Kopplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Scheffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter T.","family":"Klimecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Jay","family":"Gandolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan J.","family":"Cherrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.046177_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tox.2008.06.009","article-title":"Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment","volume":"250","author":"Aleksunes","year":"2008","journal-title":"Toxicology"},{"key":"10.1124\/dmd.112.046177_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/07853890802552437","article-title":"New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)","volume":"41","author":"Ali","year":"2009","journal-title":"Ann Med"},{"key":"10.1124\/dmd.112.046177_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/MMBR.66.2.250-271.2002","article-title":"Microbial methylation of metalloids: arsenic, antimony, and bismuth","volume":"66","author":"Bentley","year":"2002","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1124\/dmd.112.046177_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00316119","article-title":"The influence of liver disease on the methylation of arsenite in humans","volume":"55","author":"Buchet","year":"1984","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.112.046177_bib5","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1074\/jbc.M109.099333","article-title":"Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione","volume":"285","author":"Caballero","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.046177_bib6","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/carcin\/bgq125","article-title":"Selenium-dependent and -independent transport of arsenic by the human multidrug resistance protein 2 (MRP2\/ABCC2): implications for the mutual detoxification of arsenic and selenium","volume":"31","author":"Carew","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.112.046177_bib7","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1124\/dmd.111.041673","article-title":"Monomethylarsenic diglutathione transport by the human multidrug resistance protein 1 (MRP1\/ABCC1)","volume":"39","author":"Carew","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.046177_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0300-483X(02)00604-2","article-title":"Effect of selenite on the disposition of arsenate and arsenite in rats","volume":"186","author":"Csanaky","year":"2003","journal-title":"Toxicology"},{"key":"10.1124\/dmd.112.046177_bib9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ctrv.2007.05.001","article-title":"Arsenical-based cancer drugs","volume":"33","author":"Dilda","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1124\/dmd.112.046177_bib10","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1021\/tx900179r","article-title":"Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate","volume":"22","author":"Drobna","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.112.046177_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00204-009-0499-7","article-title":"Metabolism of arsenic in human liver: the role of membrane transporters","volume":"84","author":"Drobn\u00e1","year":"2010","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.112.046177_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0030-1267539","article-title":"Novel insights into the pathophysiology of nonalcoholic fatty liver disease","volume":"30","author":"Feldstein","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1124\/dmd.112.046177_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2009.04.002","article-title":"Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats","volume":"613","author":"Fisher","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.112.046177_bib14","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1124\/dmd.109.027466","article-title":"Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease","volume":"37","author":"Fisher","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.046177_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.taap.2011.02.007","article-title":"Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico","volume":"252","author":"Gomez-Rubio","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.112.046177_bib16","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1039\/b105834g","article-title":"Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid","volume":"16","author":"Gong","year":"2001","journal-title":"J Anal At Spectrom"},{"key":"10.1124\/dmd.112.046177_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bcp.2007.09.030","article-title":"The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury","volume":"75","author":"Gyamfi","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.046177_bib18","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1124\/dmd.110.035006","article-title":"Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease","volume":"38","author":"Hardwick","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.046177_bib19","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1124\/dmd.111.041012","article-title":"Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease","volume":"39","author":"Hardwick","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.046177_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1124\/dmd.111.041095","article-title":"Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis","volume":"40","author":"Hardwick","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.046177_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1289\/ehp.11589","article-title":"Dietary intake of methionine, cysteine, and protein and urinary arsenic excretion in Bangladesh","volume":"117","author":"Heck","year":"2009","journal-title":"Environ Health Perspect"},{"key":"10.1124\/dmd.112.046177_bib22","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/dmd.112.046177_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/tox.20509","article-title":"Effects of exogenous GSH and methionine on methylation of inorganic arsenic in mice exposed to arsenite through drinking water","volume":"25","author":"Jin","year":"2010","journal-title":"Environ Toxicol"},{"key":"10.1124\/dmd.112.046177_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/tx0342060","article-title":"Formation and urinary excretion of arsenic triglutathione and methylarsenic diglutathione","volume":"17","author":"Kala","year":"2004","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.112.046177_bib25","doi-asserted-by":"crossref","first-page":"33404","DOI":"10.1074\/jbc.M007030200","article-title":"The MRP2\/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic","volume":"275","author":"Kala","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.046177_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/CS20110060","article-title":"Methionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionine","volume":"121","author":"Kalhan","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"10.1124\/dmd.112.046177_bib27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1124\/dmd.112.046177_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/em.10192","article-title":"Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations","volume":"42","author":"Kligerman","year":"2003","journal-title":"Environ Mol Mutagen"},{"key":"10.1124\/dmd.112.046177_bib29","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/dmd.111.040592","article-title":"Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease","volume":"39","author":"Lake","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.046177_bib30","doi-asserted-by":"crossref","first-page":"32700","DOI":"10.1074\/jbc.M404912200","article-title":"Arsenic transport by the human multidrug resistance protein 1 (MRP1\/ABCC1). Evidence that a tri-glutathione conjugate is required","volume":"279","author":"Leslie","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.046177_bib31","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1124\/dmd.107.015107","article-title":"Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease","volume":"35","author":"Lickteig","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.046177_bib32","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.1074\/jbc.M110246200","article-title":"A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol","volume":"277","author":"Lin","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.046177_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1042\/BST0340330","article-title":"S-adenosylmethionine: jack of all trades and master of everything?","volume":"34","author":"Loenen","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1124\/dmd.112.046177_bib34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1006\/bbrc.2002.6489","article-title":"Role of the multidrug resistance protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice","volume":"291","author":"Lorico","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.112.046177_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1021\/tx000246h","article-title":"Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India","volume":"14","author":"Mandal","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.112.046177_bib36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmed.2007.12.003","article-title":"Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis","volume":"14","author":"Marra","year":"2008","journal-title":"Trends Mol Med"},{"issue":"Suppl 1","key":"10.1124\/dmd.112.046177_bib37","first-page":"S17","article-title":"Pathophysiology of nonalcoholic steatohepatitis","volume":"40","author":"McCullough","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1124\/dmd.112.046177_bib38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.envint.2008.07.023","article-title":"Transport pathways for arsenic and selenium: a minireview","volume":"35","author":"Rosen","year":"2009","journal-title":"Environ Int"},{"key":"10.1124\/dmd.112.046177_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.taap.2007.02.007","article-title":"Molecular processes in cellular arsenic metabolism","volume":"222","author":"Thomas","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.112.046177_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/taap.2001.9258","article-title":"The cellular metabolism and systemic toxicity of arsenic","volume":"176","author":"Thomas","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.112.046177_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0378-4274(87)90165-2","article-title":"Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit","volume":"37","author":"Vahter","year":"1987","journal-title":"Toxicol Lett"},{"key":"10.1124\/dmd.112.046177_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mrfmmm.2006.10.003","article-title":"Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells","volume":"615","author":"Wang","year":"2007","journal-title":"Mutat Res"},{"key":"10.1124\/dmd.112.046177_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.taap.2003.10.022","article-title":"Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review","volume":"198","author":"Yoshida","year":"2004","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624227902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624227902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.046177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:13:18Z","timestamp":1739909598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624227902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0090955624227902"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.046177","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered Arsenic Disposition in Experimental Nonalcoholic Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.046177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}